According to this article in the NY Times researchers at the Salk Institute in
Dr. Ronald M. Evans, leader of the Salk group, mentions:
“It’s a little bit like a free lunch without the calories.”
The pills should be able to help people who are too frail to exercise, and those who suffer from diabetes and obesity. Diet and exercise are crucial to the treatment of diabetic patients, so there is a possibility that this drug could become widely used if it passes FDA guidelines. More testing and research is still needed in order to finalize the drug before it reaches consumers.
No comments:
Post a Comment